glp 1 lilly Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk GLP-1 ad war leads to

Last reviewed: July 17, 2026 Last updated: July 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

10.1126/science.277.5332.1659 Science 52 LordiB.ProtaisP.MellierD.CastonJ

doi: 10.1186/1743-422X-9-295 23 GullnerG.KomivesT.GborjnyiR

A pre-clinical study showed that exendin-4 had a remarkable neuroprotective effect, improving the neurological deficit caused by transient middle cerebral artery occlusion in mice, and reducing neuronal loss and microglial inflammation (82)